The businesses then pointed to the size of the market as evidence that regulators needed to accommodate it. Whats especially problematic, according to Ginsberg, is that now that compounding may move ahead, few lay consumers will understand the legal difference between an FDA-approved drug and a substance permitted for compounding
Asimakopoulou, A., Panopoulos, P., Chasapis, C
This report examines the current state of that gap in detail, its regulatory context, its variation across race, ethnicity, sex, age, and disease area, and what the evidence suggests for sponsors, sites, and life-science organizations navigating compliance in 2026
Because the shell is similar to your cell membranes, your body recognizes it and allows it to pass more easily into the bloodstream and into the cells